Table of Contents
EXECUTIVE SUMMARY & INTRODUCTION
- Overview of delivery technologies for targeted delivery: past, present &
future
- Systemic targeted delivery: motivators & resistors
TARGETED DELIVERY TECHNOLOGIES
- Types of systemic targeted delivery platform in development in the pharma
industry
- Targeting ligands
- Antibody fragment conjugate delivery
- Antibody-directed enzyme pro-drug targeted delivery
- Peptide-induced release for targeted delivery
- Small molecule conjugate delivery
- Nucleomic mediated targeted intranuclear delivery
- Cobalamin mediated targeted intracellular delivery
- Non-biological targeting platforms
- Magnetically and Photosensitive targeted delivery
- Current therapeutic applications for targeted delivery
- Leading systemic targeted products in development
- Future commercial applications & opportunities
STRATEGIES OF DRUG DELIVERY COMPANIES
- Leading targeted drug delivery companies
- Strategic partnerships & acquisitions
- Intellectual property
THE TARGETED DELIVERY MARKET
- Now 2009: Approved targeted delivery product sales
- Future 2018: Global targeted-release product sales and novel targeted
delivery product sales
COMPETITOR ANALYSIS
Detailed analysis of leading companies covering:
- Proprietary delivery technology
- Applications in the pharma industry
- Management/technical expertise
- Competition within the delivery technology sector
- Products in development/approved utilising the delivery technology
- Sales forecasts of products utilising the delivery technology
- Competitor ratio analysis
Companies analysed
- Access Pharmaceuticals, Inc.
- ALZA Corporation (Johnson & Johnson)
- ArmaGen Technologies, Inc.
- Avidimer Therapeutics, Inc.
- Calando Pharmaceuticals, Inc.
- Cell Therapeutics, Inc.
- Cerulean Pharma, Inc.
- Copernicus Therapeutics, Inc.
- CytImmune Sciences, Inc.
- Diatos S.A.
- Enzon Pharmaceuticals, Inc.
- Endocyte Inc.
- Eurand N.V.
- ImmunoGen, Inc.
- ImaRx Therapeutics, Inc.
- NanoBioMagnetics, Inc.
- Nanobiotix
- NanoCarrier, Inc.
- Nano Interface Technology
- Nektar Therapeutics
- NeoPharm
- Novosom AG
- PCI Biotech Holding ASA
- Quest PharmaTech, Inc.
- Seattle Genetics
- Spherics Pharmaceuticals, Inc
- Starpharma Holdings, Ltd
- Supratek Pharma Inc.
- Tekmira Pharmaceuticals Corporation
APPENDICIES
- Global targeted approved drug sales 2008-2018
- Global targeted development drug sales 2008-2018
- Key targeted delivery companies by 2018
|
Related Report
|
View Cart
